Global Genomics and Bioinformatics Research Institute

Nonprofit profile at a glance

EIN
822499905
IRS 990 coverage
2019–2024
Forms available
Form 990 2024, Form 990-N 2018
Location
Fairfax, VA, USA
Phone
5714728123
Rating
43
Verdict
MIXED
Rating confidence
Moderate
Sector
Biomedicine, Bioengineering Research

Reported finances

Revenue
$494
Expenses
$0
Assets
$67,197
Liabilities
$0

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

4 people listed

Executive titles in this filing

  • DR K CRAIG KENT (PRESIDENT)

People named in this filing

  • DR K CRAIG KENT (PRESIDENT)
  • DR STEVE J MOTEW (DIRECTOR)
  • JOHN GAUL (SECRETARY)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The research institute is a visionary initiative with a stated mission of improving the health and quality of life of diverse communities through the application of genomics and associated molecular science to drive computation assisted intelligent individualized wellness, discover origins of disease and develop novel interventions to restore health when disease occurs.

What it reported doing in 2024

The research institute is a Virginia nonprofit, nonstock corporation organized for medical research and scientific purposes within the meaning of section 501(c)(3) of the internal revenue code of 1986, as amended (the "code"). The research institute was a visionary initiative of its principal members; inova health system foundation, university of Virginia, and george mason university, all prominent tax-exempt organizations, all of which are organizations described in section 501(c)(3) of the internal revenue code and/or state instrumentalities.inova health care services ("ihcs"), a Virginia non-stock corporation wholly controlled by inova, is the owner of the former exxonmobil campus in falls church, Virginia, (the "icph campus"). In the contribution and collaboration agreement (the "cca") entered into as of september 14, 2018 among the parties, the parties agreed to take certain actions in furtherance of retrofitting "building c" its adjoining "building towers and certain other "campus" improvements (collectively, "building c") on the icph campus, which was previously commercial office space, for research laboratories, together with space in or adjacent to building c for a vivarium and biorepository for the institute.the parties anticipated that the research institute would engage in genomics, bioinformatics and other research activities consistent with its articles of incorporation, its bylaws adopted in accordance with its articles of incorporation, applicable laws, and the research institute legislation.due to various intervening circumstances, the parties have concluded that each can better advance its respective mission by modifying the scope of the retrofitting of building c, by discontinuing the institute, and in the case of uva and inova by collaborating directly to further their respective missions at the icph campus. Accordingly, the entity is winding down and making preparations for final distribution of its assets to further the organization's and the parties' charitable purposes.

Operating model

Revenue model
Investment-supported. 100% of the money available for current operations came from recurring investment income.
Distribution model
No current program activity. The filing reports no program spending for the current year.

The verdict

MIXED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 0
  • Transparency & Controls: 90
  • Accountability: 76
  • Sustainability: 8
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 0%; rating input score 0
  • Program expense ratio: Limited
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 3 of 7 controls in place; rating input score 43
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: Limited
  • Total-asset coverage ratio: Limited
  • Liabilities to assets ratio: 0; rating input score 69; 69th percentile among comparable filings
  • Officer compensation ratio: Limited

Growth

  • Program expense growth: -41.9% per year; rating input score 0; 7th percentile among comparable filings
  • Revenue growth: -56.4% per year; rating input score 0; 7th percentile among comparable filings
  • Asset growth: -0.3% per year; rating input score 0; 38th percentile among comparable filings

Details

  • Where the money goes: 0% of revenue deployed
  • Governance: 2 of 2 board members independent · 3 of 7 filing controls reported
  • Programs: 1 filed program accomplishment
  • Leadership: top reported pay $0 · 4 people listed
  • Consistency: 11 of 11 current checks pass
  • Schedules: 2 filed schedules
  • Filing history: 5 filing years from 2019 to 2024
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Financial Efficiency: Mission deployment rate scored 0/100.
  • Moderate — Accountability: Governance controls: 3 of 6 not reported.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • High — Growth: Asset growth scored 0/100.